Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Bio-Path Holdings, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +8 vs. Q3 2024
- Shares held
- 319.1K
- +260.0K (+440.3%) vs. Q3 2024
- Total value
- $370.1K
- +$316.6K (+591.6%) vs. Q3 2024
- New holders
- 10
- 2 more added
- Sold out
- 2
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BPTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $5.29K |
| Q4 2024 | 22 | $370.1K |
| Q3 2024 | 14 | $53.5K |
| Q2 2024 | 13 | $285.1K |
| Q1 2024 | 10 | $78.6K |
| Q4 2023 | 19 | $276.5K |
| Q3 2023 | 23 | $256.6K |
| Q2 2023 | 18 | $812.0K |
| Q1 2023 | 21 | $793.1K |
| Q4 2022 | 21 | $976.3K |
| Q3 2022 | 19 | $1.47M |
| Q2 2022 | 17 | $1.59M |
| Q1 2022 | 17 | $1.51M |
| Q4 2021 | 17 | $1.70M |
| Q3 2021 | 17 | $2.23M |
| Q2 2021 | 17 | $2.94M |
| Q1 2021 | 19 | $3.31M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Bio-Path Holdings, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allworth Financial LP | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1 | $1 | 0.00% | +1 | New |
| Danske Bank A/S | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 4 | $5 | 0.00% | 00.0% | Unchanged |
| Synergy Investment Management, LLC | 5 | $6 | 0.00% | +5 | New |
| EverSource Wealth Advisors, LLC | 10 | $12 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 21 | $24 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 35 | $41 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 43 | $50 | 0.00% | +16+59.3% | Added |
| Tradewinds Capital Management, LLC | 50 | $58 | 0.00% | +50 | New |
| SBI Securities Co., Ltd. | 151 | $175 | 0.00% | +151 | New |
| JPMorgan Chase & Co | 217 | $252 | 0.00% | +217 | New |
| Tower Research Capital LLC (TRC) | 2,350 | $2.73K | 0.00% | −1,021−30.3% | Reduced |
| BlackRock, Inc. | 2,381 | $2.76K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,166 | $3.67K | 0.00% | +310+10.9% | Added |
| National Bank of Canada | 10,000 | $11.6K | 0.00% | +10,000 | New |
| Cetera Investment Advisers | 10,000 | $11.6K | 0.00% | +10,000 | New |
| Two Sigma Securities, LLC | 12,237 | $14.2K | 0.00% | +12,237 | New |
| Geode Capital Management, LLC | 12,448 | $14.4K | 0.00% | −1,150−8.5% | Reduced |
| Vanguard Group Inc | 13,502 | $15.7K | 0.00% | 00.0% | Unchanged |
| Apollon Wealth Management, LLC | 14,880 | $17.3K | 0.00% | +14,880 | New |
| Armistice Capital, LLC | 237,561 | $275.6K | 0.01% | +237,561 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,325−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,917−100.0% | Sold out |